InsightRX Labs

The future of research. Only together can we take precision medicine to new frontiers.

Project Voyager: Oncology

Our oncology platform continuously learns from a patient’s pharmacological characteristics by analyzing routinely collected biomarkers and tumor imaging data. The platform empowers Oncologists to identify an optimal cancer therapy at an individualized dosing regimen by predicting tumor progression and the likelihood of drug-related toxic events such as myelosuppression. At a population level, providers can use the InsightRX powered analytics engine to analyze prescribing patterns, investigate patient subgroups, and improve treatment guidelines.

STATUS: Recruiting clinicians to utilize new module.

Project Nova: Ophthalmology

Our Ophthalmology precision therapy platform allows opthalmogists to predict the likelihood of treatment success by forecasting visual acuity score and retinal thickness, enabling the right therapy to be administered at the right time for patients with macular degeneration

STATUS: Recruiting thought-leaders to assist in development on module.

Project Gemini: Pharmacogenomics

We combine the mechanistic framework of quantitative pharmacology with pharmacogenetics to allow clinicians to identify optimal treatment and dosing regimens for an individual patient. The Insight PGX platform utilizes genetic determinants of drug response in a contextual and quantitative manner through a pharmacometric-driven framework across several therapeutic areas.